Latest Going Concern News

Anatara Lifesciences reported a 35% rise in net loss to $1.95 million for FY25, following pivotal Phase II trial results for its GaRP product that missed the primary efficacy endpoint but showed promising secondary benefits. The company is advancing commercialisation efforts and launching a new anti-obesity project amid tightened cash reserves.

Oneview Healthcare PLC reported a 36% increase in revenue for the first half of 2025, driven by strong deployment activity and new US customers, while managing a wider net loss due to FX impacts and restructuring costs.

My Foodie Box Limited reported a significantly reduced net loss for the half year ended December 2024 following the divestment of its meal kit business. The company is actively pursuing new acquisitions and funding to restore shareholder value and regain its ASX listing.

Nutritional Growth Solutions Ltd has clarified discrepancies in its June 2025 quarterly reports, attributing changes to timing and classification adjustments, while reaffirming its financial health and governance compliance.

Resouro Strategic Metals reports a significant update to its Tiros project resource alongside a reduced quarterly loss, highlighting progress in its Brazilian exploration assets.

Anteris Technologies Global Corp. reported a $42.7 million net loss for the first half of 2025 amid advancing preparations for its pivotal DurAVR Transcatheter Heart Valve trial. The company’s recent IPO proceeds are fueling R&D and manufacturing scale-up as it targets regulatory approvals.

Coronado Global Resources reported a $172.4 million net loss for the half-year ended June 30, 2025, driven by falling metallurgical coal prices and reduced sales volumes. The company initiated liquidity measures including a $75 million coal prepayment and debt refinancing, but credit rating downgrades have cast doubt on its going concern status.

Metro Performance Glass proposes a $15–24 million recapitalisation involving a discounted rights offer and a major placement to Amari Metals, who would become the controlling shareholder.

AVITA Medical reported a 21% revenue increase in Q2 2025 driven by expanded sales and new product launches, yet continues to face net losses and liquidity challenges requiring loan covenant waivers.

Rewardle Holdings Limited reported a 2.8% revenue increase to $9.68 million for FY24 but swung to a $3.44 million net loss, driven by rising expenses and associate losses. The company expanded its footprint with acquisitions in grocery delivery and fintech, while deepening its stake in AI-powered health tech partner CloudHolter.

Novo Resources Corp. reported key drilling milestones at its Pilbara and New South Wales projects in Q2 2025, alongside a reduced net loss and ongoing liquidity challenges. The company’s exploration momentum continues despite material uncertainty over its going concern status.

Novo Resources Corp reported a reduced net loss of CAD 5.85 million for H1 2025, improving liquidity while continuing its gold exploration efforts in Australia.